Investor Relations Home

Webcast ImageWebcast
Q1 2017 Senomyx, Inc. Earnings Conference Call
04/27/17 at 2:00 p.m. PT
Webcast ImageWebcast
Senomyx, Inc. at the 16th Annual Needham Healthcare Conference
04/05/17 at 8:00 a.m. ET
Corporate Profile

Senomyx discovers novel flavor ingredients that boost taste sensations such as sweet. Our flavor ingredients help food and beverage companies create or reformulate better-for-you products, for example, by allowing them to significantly reduce the use of traditional, higher-calorie sweeteners, while maintaining the same taste. We also develop savory flavors, bitter blockers and cooling agents. Our products are used by many of the world’s leading food and beverage companies.

Stock QuoteMore »
SNMX (Common)
ExchangeNASDAQ (US Dollar)
Price$1.05
Change (%) Stock is Up 0.16 (17.98%)
Volume1,043,584
Data as of 04/28/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore »
DateTitle 
04/27/17SENOMYX ANNOUNCES FIRST QUARTER 2017 FINANCIAL RESULTS
SAN DIEGO, April 27, 2017 /PRNewswire/ -- Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners for the food, beverage, and ingredient supply industries, today reported financial results for the first quarter ended March 31, 2017. Highlights from the first quarter include: Commercial revenues increased 26% and direct sales increased 250% over the first quarter of 2016 Natural high intensity sweetener, siratose, introduced Regulatory authorization received for commercialization of a new cooling flavor ingredient "Senomyx is o... 
Printer Friendly Version
04/20/17Senomyx, Inc. Sends Letter to Shareholders
Your Board is Executing a Clear Strategic Vision and is Aligned with Best Interests of All Shareholders Your Board and Management Are Driving Value Creation at Senomyx, with Commercial Revenues up 31% in 2016 Believes Dissident Shareholder Group Lacks Experience, Has No Strategic Plan and is Seeking a Change in Control with a $305 Investment Vote the WHITE Proxy Card Today to Protect Your Investment in Senomyx SAN DIEGO--(BUSINESS WIRE)--Apr. 20, 2017-- The Board of Directors of Senomyx, Inc. (“Senomyx” or the “Company”) (NASDAQ: SNMX), a leading company using proprietary taste science te... 
Printer Friendly Version
04/18/17SENOMYX, INC. FIRST QUARTER 2017 EARNINGS CONFERENCE CALL SCHEDULED FOR APRIL 27, 2017
SAN DIEGO, April 18, 2017 /PRNewswire/ -- Senomyx, Inc. (NASDAQ:SNMX) will release its financial results for the first quarter ended March 31, 2017 on Thursday, April 27, 2017, after the close of the U.S. financial markets. The Company will also host a conference call with a live Internet broadcast that will provide a corporate update and a review of its first quarter results on the same day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). To participate in the live conference call, U.S. residents should dial 844-825-0514, and international callers should dial 315-625-6892 at least 10 minutes prior to the call start time. The conference ID for this call is 97603082. To access the li... 
Printer Friendly Version
03/30/17SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 16TH ANNUAL NEEDHAM HEALTHCARE CONFERENCE
SAN DIEGO, March 30, 2017 /PRNewswire/ -- Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners for the food, beverage and flavor industries, announced today that John Poyhonen, the Company's President and Chief Executive Officer, and Tony Rogers, Senior Vice President and Chief Financial Officer, will present an overview of Senomyx's technology and a business update on Wednesday, April 5, 2017 at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) during the 16th Annual Needham Healthcare Conference. The conference is taking place at the Westin Grand Cent... 
Printer Friendly Version
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources